RAPT Therapeutics Inc (RAPT)
8.13
-0.05
(-0.61%)
USD |
NASDAQ |
May 02, 16:00
8.25
+0.12
(+1.48%)
Pre-Market: 09:24
RAPT Therapeutics Accounts Payable (Quarterly): 5.176M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.176M |
September 30, 2023 | 5.297M |
June 30, 2023 | 2.69M |
March 31, 2023 | 8.941M |
December 31, 2022 | 3.365M |
September 30, 2022 | 4.043M |
June 30, 2022 | 4.097M |
March 31, 2022 | 1.936M |
December 31, 2021 | 1.999M |
September 30, 2021 | 4.017M |
June 30, 2021 | 2.714M |
Date | Value |
---|---|
March 31, 2021 | 3.131M |
December 31, 2020 | 2.383M |
September 30, 2020 | 4.405M |
June 30, 2020 | 2.381M |
March 31, 2020 | 3.409M |
December 31, 2019 | 1.143M |
September 30, 2019 | 1.59M |
June 30, 2019 | 2.604M |
March 31, 2019 | 1.32M |
December 31, 2018 | 1.771M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.143M
Minimum
Dec 2019
8.941M
Maximum
Mar 2023
3.438M
Average
3.131M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
Emergent BioSolutions Inc | 112.20M |
Avinger Inc | 0.777M |
Tonix Pharmaceuticals Holding Corp | 3.782M |
Skye Bioscience Inc | 1.156M |
Axsome Therapeutics Inc | 40.68M |